ChoA Pharmaceutical Co Ltd
KOSDAQ:034940
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
ChoA Pharmaceutical Co Ltd
Pre-Tax Income
ChoA Pharmaceutical Co Ltd
Pre-Tax Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
ChoA Pharmaceutical Co Ltd
KOSDAQ:034940
|
Pre-Tax Income
-₩6.4B
|
CAGR 3-Years
-147%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
|
Yuhan Corp
KRX:000100
|
Pre-Tax Income
₩222.7B
|
CAGR 3-Years
33%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
3%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Pre-Tax Income
₩150.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Pre-Tax Income
₩213.5B
|
CAGR 3-Years
21%
|
CAGR 5-Years
57%
|
CAGR 10-Years
0%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Pre-Tax Income
₩12.5B
|
CAGR 3-Years
12%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-5%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Pre-Tax Income
₩22.4B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
ChoA Pharmaceutical Co Ltd
Glance View
ChoA Pharmaceutical Co., Ltd. engages in the manufacture and sale of medicine and health supplement food. The company is headquartered in Seoul, Seoul. The Company’s products are mainly for treatment of indigestion, gastric ulcer, duodenal ulcer, gastritis, gastric hyperacidity, intestinal disorder, constipation, diarrhea, stomachache, calcium deficiency, fatigue, iron deficiency anemia, neurasthenia, hypertension, hyperlipidemia, circulatory disorder, medicine poisoning, hepatic disease, allergic rhinitis, cough, cold, rheumatoid arthritis and others. The company also provides nutrition products, health drinks, mixed drinks, beverages for children, cosmetics and others.
See Also
What is ChoA Pharmaceutical Co Ltd's Pre-Tax Income?
Pre-Tax Income
-6.4B
KRW
Based on the financial report for Dec 31, 2025, ChoA Pharmaceutical Co Ltd's Pre-Tax Income amounts to -6.4B KRW.
What is ChoA Pharmaceutical Co Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
-29%
Over the last year, the Pre-Tax Income growth was 36%. The average annual Pre-Tax Income growth rates for ChoA Pharmaceutical Co Ltd have been -147% over the past three years , -29% over the past five years .
